You need to enable JavaScript to run this app.
Experts worried about exceptions process handling under DSCSA
Regulatory News
Joanne S. Eglovitch
Biologics/ biosimilars/ vaccines
Biotechnology
Compliance
North America
Pharmaceuticals
Product Lifecycle
Quality Assurance and Control
Regulatory Intelligence/Policy